Per Edelmann is an industry advisor at EQT Group and operates as an independent advisor for British International Investment. They possess extensive experience in executive management roles across multibillion-dollar pharmaceutical companies, including Teva and Mylan Inc., with a strong focus on international growth, marketing, and organizational development. Previously, Per served on the boards of various organizations and has a robust background in M&A processes, financial management, and brand expansion. Per's educational credentials include programs from prestigious institutions such as Harvard Business School and The Wharton School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices